We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+34.39%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$65.8B
AUM Growth
+$8.44B
Cap. Flow
-$768M
Cap. Flow %
-1.17%
Top 10 Hldgs %
21.16%
Holding
3,797
New
262
Increased
1,942
Reduced
1,268
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 10.51%
2 Financials 8.9%
3 Healthcare 8.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACH
3401
Accendra Health
ACH
$107M
$83K ﹤0.01%
20,172
+956
+5% +$6.05K
TGLS icon
3402
Tecnoglass Holdings Inc.
TGLS
$1.84B
$83K ﹤0.01%
+11,400
New +$93.5K
NTBL
3403
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$83K ﹤0.01%
1,554
SMRT
3404
DELISTED
Stein Mart Inc
SMRT
$82K ﹤0.01%
82,377
+5,875
+8% +$6.64K
EPM icon
3405
Evolution Petroleum
EPM
$134M
$79K ﹤0.01%
11,644
-180
-2% -$1.31K
HEXO
3406
DELISTED
HEXO Corp. Common Shares
HEXO
$79K ﹤0.01%
+214
New +$69.3K
GEN
3407
DELISTED
Genesis Healthcare, Inc.
GEN
$79K ﹤0.01%
55,000
BP icon
3408
CALL
BP
BP
$110B
$76K ﹤0.01%
119,278
-1,646
-1% -$67.5K
BKCC
3409
DELISTED
BlackRock Capital Investment Corporation
BKCC
$75K ﹤0.01%
12,595
-2,750
-18% -$16.8K
CRWS icon
3410
Crown Crafts
CRWS
$32M
$74K ﹤0.01%
14,300
-3,000
-17% -$16.7K
SILV
3411
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$74K ﹤0.01%
22,674
+9,490
+72% +$32.9K
CNR
3412
DELISTED
Cornerstone Building Brands, Inc.
CNR
$74K ﹤0.01%
11,947
-209
-2% -$1.53K
DFS
3413
CALL
DELISTED
Discover Financial Services
DFS
$73K ﹤0.01%
17,700
-4,800
-21% -$329K
QQQ icon
3414
CALL
Invesco QQQ Trust
QQQ
$479B
$72K ﹤0.01%
+23,000
New +$3.9M
CVS icon
3415
CALL
CVS Health
CVS
$122B
$71K ﹤0.01%
68,000
-2,500
-4% -$154K
AMPE
3416
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$71K ﹤0.01%
420
+367
+692% +$62.9K
CVX icon
3417
CALL
Chevron
CVX
$382B
$70K ﹤0.01%
91,200
+40,800
+81% +$4.83M
RAD
3418
DELISTED
Rite Aid Corporation
RAD
$69K ﹤0.01%
5,467
-6,217
-53% -$95.9K
MU icon
3419
CALL
Micron Technology
MU
$972B
$68K ﹤0.01%
+28,400
New +$1.1M
AKS
3420
DELISTED
AK Steel Holding Corp
AKS
$68K ﹤0.01%
24,798
-9,061
-27% -$25.7K
AHT
3421
Ashford Hospitality Trust
AHT
$20.7M
$67K ﹤0.01%
14
AAU
3422
DELISTED
Almaden Minerals Ltd
AAU
$67K ﹤0.01%
114,924
-195,949
-63% -$136K
DSE
3423
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$67K ﹤0.01%
1,338
-72
-5% -$3.5K
CPRX
3424
DELISTED
Catalyst Pharmaceutical
CPRX
$66K ﹤0.01%
13,007
-2,000
-13% -$5.88K
KNDI
3425
Kandi Technologies Group
KNDI
$63.1M
$66K ﹤0.01%
11,700
+100
+0.9% +$620

Similar funds

Raymond James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Raymond James & Associates held 3,797 positions worth $65.8B, up 15% from $57.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q1 2019 filing shows 262 new, 1,942 increased, 1,268 reduced and 186 closed positions. Its largest new stake was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M. The largest sale was TotalEnergies, an estimated $2.56B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2019 buy was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q1 2019, an estimated $371M increase.
  • Raymond James & Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $2.56B.
  • Raymond James & Associates fully exited iShares Core 80/20 Aggressive Allocation ETF in Q1 2019, selling an estimated $26.3M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $65.8B portfolio in Q1 2019.
  • Raymond James & Associates opened 262 new positions and closed 186 in Q1 2019.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $65.8B.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.